On June 3, 2025, it was reported that meloxicam, a nonsteroidal anti-inflammatory drug, has been detected in canned food products originating from the United States of America. This discovery has raised significant concerns regarding food safety and the potential contamination of consumer products.
The incident has been categorized under fraud, highlighting the serious nature of the issue as it pertains to the integrity of food production and distribution systems. The presence of meloxicam in food products poses risks, as it is not an approved ingredient for human consumption in these contexts.
This finding has been officially communicated by the Federal Service for Veterinary and Phytosanitary Surveillance, known as Россельхознадзор. The agency is responsible for monitoring food safety standards and ensuring that products meet regulatory requirements.
As investigations continue, authorities are focusing on identifying the source of contamination and taking appropriate measures to protect consumers. The detection of contaminants such as meloxicam in food products underscores the importance of strict oversight within the food industry to prevent similar incidents in the future.